About the journal
Oncology Reviews is an open-access journal published by Frontiers Media S.A. in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 1,950 CHF. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Frontiers Media S.A.
- ISSN
- 1970-5565 · 1970-5557
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,950 CHF
- Articles in DOAJ
- 499
- Declared review time
- 15 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.frontiersin.org/journals/oncology-reviews
Index listings
- DOAJ · 2013-04-05
- PUBMED · 2011-06-01
- Indexing
- DOAJ · PUBMED
- APC
- 1,950 CHF
- Declared review time (DOAJ)
- 15 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
499
Most recent article
last month
Average review time (journal-declared via DOAJ)
15weeks
Works in OpenAlex
820
Last recorded publication year
2026
h-index
41
i10-index
163
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-03-12
- Added to DOAJ
- 2013-04-05
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPKP PNPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- OR
- Source type
- journal
- NLM unique ID (PubMed)
- 101519906
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
Show all subjects (50)
- Renal cell carcinoma treatment
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
- Cervical Cancer and HPV Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Cervical Cancer and HPV Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Treatments and Mutations
- Estrogen and related hormone effects
- Chronic Lymphocytic Leukemia Research
- Estrogen and related hormone effects
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Endometrial and Cervical Cancer Treatments
- Cancer Immunotherapy and Biomarkers
- Endometrial and Cervical Cancer Treatments
- BRCA gene mutations in cancer
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- BRCA gene mutations in cancer
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Renal and related cancers
- Multiple Myeloma Research and Treatments
- Immunotherapy and Immune Responses
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer Cells and Metastasis
- Brain Metastases and Treatment
- Multiple Myeloma Research and Treatments
- Cancer Cells and Metastasis
Keywords (DOAJ)
- cancer research
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ